Seroprevalence of Anti-SARS-CoV-2 Antibodies among Outpatients in Southwestern Seoul, Korea

J Korean Med Sci. 2020 Aug 24;35(33):e311. doi: 10.3346/jkms.2020.35.e311.

Abstract

Serosurveillance studies reveal the actual disease burden and herd immunity level in the population. In Seoul, Korea, a cross-sectional investigation showed 0.07% anti-severe acute respiratory syndrome coronavirus-2 antibody seropositivity among 1,500 outpatients of the university hospitals. Low seroprevalence reflects well-implemented social distancing. Serosurveillance should be repeated as the pandemic progresses.

Keywords: COVID-19; SARS-CoV-2; Seroepidemiology; Seroprevalence.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Viral / blood*
  • Betacoronavirus / immunology*
  • COVID-19
  • Child
  • Child, Preschool
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology
  • Cross-Sectional Studies
  • Female
  • Hospitals, University
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Middle Aged
  • Outpatients
  • Pandemics
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology
  • SARS-CoV-2
  • Seoul / epidemiology
  • Seroepidemiologic Studies
  • Young Adult

Substances

  • Antibodies, Viral